Clinical Effectiveness of Biphasic Insulin Aspart 30:70 Versus Biphasic Human Insulin 30 in UK General Clinical Practice: A Retrospective Database Study (vol 1, pg 27, 2011)

被引：0

|

作者：

Morgan, C. Ll

机构：

来源：

CLINICAL THERAPEUTICS | 2011年 / 33卷 / 03期

关键词：

D O I：

10.1016/j.clinthera.2011.03.007

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：391 / 391

页数：1

相关论文

共 50 条

[1] Clinical Effectiveness of Biphasic Insulin Aspart 30:70 Versus Biphasic Human Insulin 30 in UK General Clinical Practice: A Retrospective Database Study
Morgan, Christopher Li
Evans, Marc
Toft, Anders D.
Jenkins-Jones, Sara
Poole, Chris D.
Currie, Craig J.
CLINICAL THERAPEUTICS, 2011, 33 (01) : 27 - 35
[2] Switching to biphasic insulin aspart 30/50/70 from biphasic human insulin 30/50 in patients with type 2 diabetes in normal clinical practice: observational study results
Nobels, Frank
D'Hooge, Dirk
Crenier, Laurent
CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (06) : 1017 - 1026
[3] Switching to biphasic insulin aspart 30/50/70 from biphasic human insulin 30/50 in patients with type 2 diabetes in normal clinical practice: observational study results (vol 28, pg 1017, 2012)
Nobels, F.
D'Hooge, D.
Crenier, L.
CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (09) : 1546 - 1546
[4] Biphasic insulin aspart 30 (BIAsp 30) in clinical reality: Experience from a Dutch practice
Ligthelm, Robert J.
DIABETES, 2007, 56 : A540 - A540
[5] GLYCAEMIC CONTROL AND INSULIN UTILIZATION IN UK PATIENTS WITH TYPE 2 DIABETES INITIATED ON EITHER BIPHASIC INSULIN ASPART 30 OR BIPHASIC HUMAN INSULIN 30
Fakhoury, W.
Richter, H.
Christensen, T.
Thomsen, T. L.
Irwin, D.
Anderson, P.
VALUE IN HEALTH, 2010, 13 (03) : A55 - A55
[6] Clinical safety and effectiveness of biphasic insulin aspart 30 in type 2 diabetes patients switched from biphasic human insulin 30: Results from the Indonesian cohort of the A1chieve study
Soewondo, Pradana
Lindarto, Dharma
Wibisono, Sony
Renaldi, Olly
Dalem-Pemayun, Tjokorda Gde
DIABETES RESEARCH AND CLINICAL PRACTICE, 2013, 100 : S41 - S46
[7] Biphasic insulin aspart 30/70 (BIAsp 30) in the treatment of type 1 and type 2 diabetes
Valensi, Paul
DIABETES METABOLIC SYNDROME AND OBESITY, 2009, 2 : 61 - 71
[8] A comparison of pharmocodynamics and pharmacokinetics of Biphasic Insulin Aspart 30, 50, 70 & Pure Insulin Aspart in type 1 diabetes
Thorisdottir, Rannveig L.
Parkner, Tina
Chen, Jian-Wen
Ejskjaer, Niels
Christiansen, Jens S.
DIABETES, 2007, 56 : A555 - A555
[9] Starting patients with type 2 diabetes on insulin therapy using once-daily injections of biphasic insulin aspart 70/30, biphasic human insulin 70/30, or NPH insulin in combination with metformin
Kilo, C
Mezitis, N
Jain, R
Mersey, J
McGill, J
Raskin, P
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2003, 17 (06) : 307 - 313
[10] Cost-effectiveness of biphasic insulin aspart 30 versus human premix insulin for type 2 diabetes patients in China
Lynch, M.
Scheijbeler, H.
Kotchie, R.
Neilsen, S.
White, J.
Valentine, W. J.
VALUE IN HEALTH, 2007, 10 (06) : A262 - A262

← 1 2 3 4 5 →